Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
The New Zealand Medical Journal|September 27, 2003
Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New ZealandMira Harrison-Woolrych, Lifeng Zhou, David Coulter
Contraception|December 25, 2002
Insertion of the Multiload Cu375 intrauterine device; experience in over 16,000 New Zealand womenMira Harrison-Woolrych, Janelle Ashton, David Coulter
Contraception|May 16, 2009
A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescentsHelen Paterson, Janelle Ashton, Mira Harrison-Woolrych
Pharmacoepidemiology and Drug Safety|August 9, 2013
Exposure to the smoking cessation medicine varenicline during pregnancy: a prospective nationwide cohort studyMira Harrison-Woolrych, Helen Paterson, Ming Tan
BMJ Sexual & Reproductive Health|October 12, 2019
Pregnancies associated with etonogestrel implants in the UK: comparison of two 5-year reporting periodsSam Rowlands, Emma Cornforth, Mira Harrison-Woolrych
Pharmacoepidemiology and Drug Safety|August 6, 2003
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)Lifeng Zhou, Mira Harrison-Woolrych, David M Coulter
Pharmacoepidemiology and Drug Safety|July 31, 2007
Sibutramine usage in New Zealand: an analysis of prescription data by the Intensive Medicines Monitoring ProgrammeGeraldine R Hill, Janelle Ashton, Mira Harrison-Woolrych
The New Zealand Medical Journal|October 9, 2008
Pharmacovigilance in New Zealand: the role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines useDesiree L Kunac, Mira Harrison-Woolrych, Michael V Tatley
Drug Safety|July 3, 2007
Safety and usage of atypical antipsychotic medicines in children: a nationwide prospective cohort studyMira Harrison-Woolrych, Juan Garcia-Quiroga, Janelle Ashton, et al.
Pageof 4